NEW YORK, April 26, 2017 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired shares of INSYS Therapeutics, Inc. (“INSYS”) (NASDAQ:INSY) between February 23, 2016 and March 15, 2017. You are hereby notified that Levi & Korsinsky has commenced the class action Erdmann v. INSYS Therapeutics, Inc.., et al. (Case No. 1:17-cv-02225) in the USDC for the Southern District of New York. Click here to view the complaint. To get more information go to:
http://www.zlk.com/pslra/insys-therapeutics-inc?wire=3
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The complaint alleges that throughout the Class Period Defendants made false and/or misleading statements and/or failed to disclose that: (1) INSYS had overstated its 2015 net revenue; (2) INSYS had misstated its sales allowances for 2016; (3) accordingly, the Company lacked effective internal controls over financial reporting; and (4) as a result, INSYS public statements were materially false and misleading at all relevant times.
Take Action: if you suffered a loss in INSYS you have until May 16, 2017 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


Starbucks Raises 2026 Outlook as Turnaround Strategy Boosts Sales and Earnings
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth
DeepSeek Slashes AI Model Pricing to Boost Adoption and Challenge Global Rivals
T-Mobile Beats Q1 Earnings Expectations on Strong Postpaid Growth
Meta Raises 2026 Capex Outlook Amid AI Spending Surge, Shares Drop After Earnings
Why Paycom Was Named a 2026 Platinum Employer on the Where You Work Matters List
Spirit Airlines Gains Key Creditor Support for $500M Bailout Deal
Pershing Square Raises $5 Billion in Landmark U.S. IPO and Share Placement
Samsung Reports Record Profit as AI Boom Drives Memory Chip Demand
Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector
TSMC Exits Arm Holdings with $231 Million Share Sale Amid Strategic Portfolio Shift
Google Secures Pentagon AI Deal for Classified Projects
Alphabet Earnings Surge on AI Growth, Cloud Revenue, and Strong Search Performance
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand 



